Vanguard reports 7.49% stake in Johnson & Johnson
Johnson & Johnson reported that Vanguard Capital Management beneficially owned 180,631,228 shares of Common Stock, representing 7.49% of the class as of 03/31/2026.
Rhea-AI Filing Summary
Johnson & Johnson reported that Vanguard Capital Management beneficially owned 180,631,228 shares of Common Stock, representing 7.49% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 180,631,228 shares and sole voting power for 24,025,858 shares.
Positive
- None.
Negative
- None.
Insights
Vanguard holds a 7.49% stake in Johnson & Johnson with broad dispositive authority.
Vanguard Capital Management reports beneficial ownership of 180,631,228 shares as of 03/31/2026, with sole dispositive power over that same amount and sole voting power over 24,025,858 shares. The filing notes holdings include assets managed across Vanguard affiliates and client accounts.
Implications depend on trading by Vanguard funds or clients; the schedule discloses ownership but does not state intended transactions. Subsequent filings would show material changes in stake or voting alignment.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power regulatory
sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management report in JNJ?
Are Vanguard's JNJ holdings held on behalf of others?
What are the relevant dates and filing details for this disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.